Latest Sanctions News

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a brief delay as FIRB extends its approval deadline, prompting a reschedule of the critical court hearing to November 23.

Brightstar Resources has received court approval to acquire Aurumin Limited, consolidating the Sandstone Gold Project and boosting its combined mineral resource to 2.4 million ounces. The acquisition positions Brightstar as a rising mid-tier gold producer in Western Australia.

Aurumin Limited shareholders and optionholders convened on 14 November 2025 to vote on a scheme of arrangement for Brightstar Resources to acquire 100% of Aurumin, with strong proxy support signaling broad approval ahead of final court sanction.

Tamboran Resources has sanctioned its Shenandoah South Pilot Project, completed a record drilling campaign, and is progressing infrastructure to deliver gas to the Northern Territory by mid-2026. The company also announced a planned acquisition of Falcon Oil & Gas and raised $56 million in a public offering.

Infomedia Limited has secured Foreign Investment Review Board approval for its proposed acquisition by TPG Capital-backed McQueen BidCo, marking a key regulatory milestone. The Infomedia Board continues to recommend shareholder support ahead of upcoming votes.

Capricorn Metals Ltd has officially completed its acquisition of Warriedar Resources Limited through a court-approved scheme of arrangement, marking a significant consolidation in the gold mining sector.

Marimaca Copper's Chilean subsidiary has obtained formal environmental approval for its Marimaca Oxide Project, clearing a critical hurdle toward construction readiness in the second half of 2026. This milestone follows years of environmental and social groundwork and sets the stage for the next permitting phase.

Mayne Pharma updates shareholders on the extended Foreign Investment Review Board approval deadline and the rescheduled court hearing for its acquisition scheme by Cosette Australia BidCo.

Capstone Copper delivered a landmark Q3 2025 with record revenue, lowest-ever cash costs, and a strategic joint venture that derisks its Santo Domingo project. The company’s growth trajectory is bolstered by robust production gains and promising exploration results.

Ampol Limited reported a robust third quarter in 2025 with refinery margins hitting a notable high, offsetting volume declines and setting the stage for strategic growth.

Aguia Resources Limited’s AGRO securities have been suspended from trading by ASX Compliance, pending regulatory compliance. The move raises questions about the company’s current standing and next steps.

Mayne Pharma has announced the rescheduling of its Supreme Court hearing to November 3, 2025, to approve the acquisition scheme by Cosette Australia BidCo, pending Foreign Investment Review Board approval.